Celltaxis Names Co-Founder Eileen Heffernan as CEO to Accelerate Growth and Expand Leadership in Lymphatic Disease Therapeutics

Ms. Heffernan to advance Celltaxis' strategic partnering initiatives at BIO San Diego, being held June 22-25, 2026, in San Diego, California ATLANTA, June 15, 2026 /PRNewswire/ -- Celltaxis, a clinical-stage biotechnology company dedicated to developing novel therapies for lymphatic...